Hard Choices: How Does Injustice Affect the Ethics of Medical Aid in Dying?

Camb Q Healthc Ethics

Huntsman Mental Health Institute, Department of Psychiatry, University of Utah, Salt Lake City, UT, USA.

Published: October 2023

Critics of medical aid in dying (MAID) often argue that it is impermissible because background social conditions are insufficiently good for some persons who would utilize it. I provide a critical evaluation of this view. I suggest that receiving MAID is a sort of "hard choice," in that death is bad for the individual and only promotes that person's interests in special circumstances. Those raising this objection to MAID are, I argue, concerned primarily about the effects of injustice on hard choices. I show, however, that MAID and other hard choices are not always invalidated by injustice and that what matters is whether the injustice can be remediated given certain constraints. Injustice invalidates a hard choice when it can, reasonably, be remedied in a way that makes a person's life go better. I consider the implications of this view for law and policy regarding MAID.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0963180123000531DOI Listing

Publication Analysis

Top Keywords

hard choices
12
medical aid
8
maid argue
8
injustice
5
maid
5
hard
4
choices injustice
4
injustice affect
4
affect ethics
4
ethics medical
4

Similar Publications

Metabolic factors modulate effort-based decision-making in major depressive disorder.

J Affect Disord

December 2024

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

Background: Abnormalities in effort-based decision-making have been consistently reported in major depressive disorder (MDD). Evidence indicates that metabolic factors, such as insulin resistance and dyslipidemia, which are highly prevalent in MDD, are independently associated with reward disturbances. Herein, we investigate the moderating effect of metabolic factors on effort-based decision-making in individuals with MDD.

View Article and Find Full Text PDF

Background: The POCSO (Protection Of Children from Sexual Offences) Act was introduced in 2012 as a measure to safeguard and prevent interests of children affected by sexual crimes. Both medical and dental professionals are capable of identifying such cases.

Aim: The aim of this study was to evaluate the knowledge and awareness of child sexual abuse related to POCSO Act among both medical and dental professionals in India.

View Article and Find Full Text PDF

The main principles of management of children with root fractures of permanent teeth in the coronal third are presented using two clinical cases as an example. In the treatment of root fractures in the coronal third, an important condition for success is timely flexible or semi-flexible splinting of the tooth for a sufficiently long period (up to 4 months). In the absence of splinting or significant mobility of the coronal fragment after removal of the splint the probability of pulp necrosis is very high, and the method of choice is treatment with calcium silicate cements with their introduction by orthograde or surgical access.

View Article and Find Full Text PDF

Introduction Existing research has established that some people struggle with prescription charges. This paper reports on the experiences of a sub-sample of people who participated in the FreeMeds study (a randomised controlled trial of prescription charges) about their problems paying for medicines. Aim The aim of this study was to explore participants' previous experiences with paying for medicines, and the impact of receiving free medicines through the Free Meds study.

View Article and Find Full Text PDF

Non-alcoholic steatohepatitis (NASH) is a potential serious disease, which almost has no available medicine for effective treatment today. Efruxifermin is a bivalent Fc-FGF21 candidate drug developed by Akero Therapeutics that has shown promising results in preclinical and clinical trials for NASH and may be approved in future. However, it is produced by Escherichia coli (E.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!